Advertisement
Research Article| Volume 231, P143-149, March 15, 2017

Download started.

Ok

Carotid plaque detection improves the predictive value of CHA2DS2-VASc score in patients with non-valvular atrial fibrillation: The ARAPACIS Study

Published:January 04, 2017DOI:https://doi.org/10.1016/j.ijcard.2017.01.001

      Abstract

      Background and aims

      Vascular disease (VD), as assessed by history of myocardial infarction or peripheral artery disease or aortic plaque, increases stroke risk in atrial fibrillation (AF), and is a component of risk assessment using the CHA2DS2-VASc score. We investigated if systemic atherosclerosis as detected by ultrasound carotid plaque (CP) could improve the predictive value of the CHA2DS2-VASc score.

      Methods

      We analysed data from the ARAPACIS study, an observational study including 2027 Italian patients with non-valvular AF, in whom CP was detected using Doppler Ultrasonography.

      Results

      VD was reported in 351 (17.3%) patients while CP was detected in 16.6% patients. Adding CP to the VD definition leaded to higher VD prevalence (30.9%).
      During a median [IQR] follow-up time of 36 months, 56 (2.8%) stroke/TIA events were recorded. Survival analysis showed that conventional VD alone did not increase the risk of stroke (Log-Rank: 0.009, p = 0.924), while addition of CP to conventional VD was significantly associated to an increased risk of stroke (LR: 5.730, p = 0.017). Cox regression analysis showed that VD + CP was independently associated with stroke (HR: 1.78, 95% CI: 1.05–3.01, p = 0.0318). Reclassification analysis showed that VD + CP allowed a significant risk reclassification when compared to VD alone in predicting stroke at 36 months (NRI: 0.192, 95% CI: 0.028–0.323, p = 0.032).

      Conclusions

      In non-valvular AF patients the addition of ultrasound detection of carotid plaque to conventional VD significantly increases the predictive value of CHA2DS2-VASc score for stroke.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to International Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kirchhof P.
        • Breithardt G.
        • Bax J.
        • et al.
        A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference.
        Europace. 2016; 18: 37-50
        • Lip G.Y.
        • Lane D.A.
        Stroke prevention in atrial fibrillation: a systematic review.
        JAMA. 2015; 313: 1950-1962
        • Ruff C.T.
        • Giugliano R.P.
        • Braunwald E.
        • et al.
        Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.
        Lancet. 2014; 383: 955-962
        • Violi F.
        • Daví G.
        • Hiatt W.
        • et al.
        Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy.
        J. Am. Coll. Cardiol. 2013; 62: 2255-2256
        • Pastori D.
        • Pignatelli P.
        • Angelico F.
        • et al.
        Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors.
        Chest. 2015; 147: 1644-1650
        • Violi F.
        • Loffredo L.
        Thromboembolism or atherothromboembolism in atrial fibrillation?.
        Circ. Arrhythm. Electrophysiol. 2012; 5: 1053-1055
        • Lip G.Y.
        • Nieuwlaat R.
        • Pisters R.
        • et al.
        Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.
        Chest. 2010; 137: 263-272
        • Violi F.
        • Davì G.
        • Proietti M.
        • et al.
        Ankle-brachial index and cardiovascular events in atrial fibrillation: ARAPACIS prospective study.
        Thromb. Haemost. 2016; 115: 856-863
        • Raparelli V.
        • Proietti M.
        • Buttà C.
        • et al.
        Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study.
        Intern. Emerg. Med. 2014; 9: 861-870
        • Stein J.H.
        • Korcarz C.E.
        • Hurst R.T.
        • et al.
        Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine.
        J. Am. Soc. Echocardiogr. 2008; 21: 93-111
        • Pencina M.J.
        • D'Agostino Sr., R.B.
        • Steyerberg E.W.
        Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.
        Stat. Med. 2011; 30: 11-21
        • Vickers A.J.
        • Cronin A.M.
        • Elkin E.B.
        • et al.
        Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers.
        BMC Med. Inform. Decis. Mak. 2008; 8: 53
        • Heagerty P.J.
        • Lumley T.
        • Pepe M.S.
        Time-dependent ROC curves for censored survival data and a diagnostic marker.
        Biometrics. 2000; 56: 337-344
        • Proietti M.
        • Calvieri C.
        • Malatino L.
        • et al.
        Relationship between carotid intima-media thickness and non valvular atrial fibrillation type.
        Atherosclerosis. 2015; 238: 350-355
        • Bekwelem W.
        • Jensen P.N.
        • Norby F.L.
        • Soliman E.Z.
        • Agarwal S.K.
        • Lip G.Y.
        • Pan W.
        • Folsom A.R.
        • Longstreth Jr., W.T.
        • Alonso A.
        • Heckbert S.R.
        • Chen L.Y.
        Carotid atherosclerosis and stroke in atrial fibrillation: the Atherosclerosis Risk in Communities Study.
        Stroke. 2016; 47: 1643-1646
        • Violi F.
        • Calvieri C.
        • Ferro D.
        • et al.
        Statins as antithrombotic drugs.
        Circulation. 2013; 127: 251-257
        • Pepe M.S.
        • Fan J.
        • Feng Z.
        • Gerds T.
        • Hilden J.
        The Net Reclassification Index (NRI): a misleading measure of prediction improvement even with independent test data sets.
        Stat. Biosci. 2015; 7: 282-295